Search results for: Innovation Policy Prize

Bhaven N. Sampat

20 January 2023

…Economic Research (NBER). Bhaven has written extensively on life science and pharmaceutical innovation policy, including work on U.S. pharmaceutical patenting, brand–generic competition, gene patents and follow–on innovation, the globalization of…

Around The World in HTAs: Thailand – An Ever-Evolving Policy Tool

9 September 2024

…the development of innovations by evaluating them at their developmental stages, scan and streamline the innovation process by identifying health needs and gaps and estimate and maximise their value early…

Margaret Kyle

3 February 2023

…published in various journals of economics, strategy, health policy and competition policy, including the Quarterly Journal of Economics, RAND Journal of Economics, Review of Economics and Statistics, Journal of Law…

H.R. 3 is the Wrong Policy for the Wrong Problem

10 September 2021

US policy makers are discussing an attempt to lower prescription drug spending in the US. US policy makers are currently discussing the Elijah E. Cummings Lower Drug Costs Now Act…

Economics of Innovation

Economics of Innovation OHE conducts multi-disciplinary research to support sustainable incentives for health technology development that advances patient care and maximises the value of innovation for society. We use mixed-methods…

Partnerships for Health System Innovation and Improvement

12 September 2023, 3:00pm

…valued outcomes. However, the adoption and uptake of innovation is often hampered by a variety of barriers concerning technological advances, health system complexity, and stakeholder engagement. Overcoming barriers to innovation…

The Use of Pay-for-Performance for Drugs: Can It Improve Incentives for Innovation?

1 February 2012

…innovation. The authors conclude that “pay-for-performance” offers an important way forward to both handle uncertainty around expected value in routine clinical practice and provide the rewards essential for continued innovation….

The commercial case for investing in ALS

13 November 2025

…and innovation in ALS therapies.  Share this: Download publication Amyotrophic lateral sclerosis (ALS) is a rare, rapidly progressive neurodegenerative disease with devastating clinical and economic consequences. Despite its relatively low…

Medicines for the year 2000

1 September 1979

…effective and safe medicine. This industry competes in an international market in which success depends critically on innovation. About two years ago a report by the Economic Development Committee for…